Risk factors, clinical characteristics, and outcomes of lower limb cellulitis in a tertiary hospital in Iran
Main Article Content
Abstract
Lower limb cellulitis is a frequent bacterial infection associated with substantial morbidity, yet epidemiological data from Iran remain limited. This retrospective cross-sectional study analyzed the medical records of 120 patients admitted to a tertiary hospital in Zanjan, Iran, with lower limb cellulitis between July and December 2023. The mean age was 53.3 years, and 65.0% of the participants were male. The average duration of hospitalization was 6.3 ± 5.4 days. Hypertension (28.3%) and diabetes mellitus (17.5%) were the most common comorbidities. Trauma was the leading precipitating factor, reported in 50.0% of cases, and was significantly more frequent among males (p=0.007). Abscess formation occurred in 29.2% of patients and was strongly associated with trauma (p=0.001) and previous cellulitis (p=0.046). Hypertension and diabetes were more common among female patients, although their older mean age may partially confound this. A history of deep vein thrombosis and recurrent cellulitis was associated with prolonged hospitalization. These findings highlight trauma as the predominant risk factor for cellulitis in this population, with comorbid diabetes further worsening clinical outcomes. The results underscore the need for preventive strategies, including patient education on wound care, strict control of chronic diseases, and targeted interventions for high-risk groups such as diabetic patients and manual laborers. Despite providing valuable regional insight, the study is limited by its retrospective single-center design, reliance on univariate analysis, small subgroup sizes, and potential data inconsistencies. Future prospective, multi-center studies are warranted to validate and expand these observations.
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
[1] Gunderson CG. Cellulitis: definition, etiology, and clinical features. Am J Med. 2011;124(12):1113-22.
DOI: 10.1016/j.amjmed.2011.06.028 PMID: 22014791
[2] Elsayed SM, Elbana HA. Risk Factors Associated with Occurrence of Cellulitis in Critically Ill Patients with Fulminant Hepatic Failure. Menoufia Nursing Journal. 2022;7(2):135–47. DOI: 10.21608/menj.2022.315243
[3] Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev. 2017;6:CD009758. DOI: 10.1002/14651858.CD009758.pub2
[4] Yoshida S, Koshima I, Imai H, Roh S, Mese T, Uchiki T, et al. Lymphaticovenous Anastomosis for Age-Related Lymphedema. J Clin Med. 2021;10:5129. DOI: 10.3390/jcm10215129
[5] Raff AB, Kroshinsky D. Cellulitis: a review. JAMA. 2016;316(3):325–37. DOI: 10.1001/jama.2016.8825
[6] Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology. 2007;215:118–22. DOI: 10.1159/000104262
[7] Tay EY, Fook-Chong S, Oh CC, Thirumoorthy T, Pang SM, Lee HY. Cellulitis Recurrence Score: A tool for predicting recurrence of lower limb cellulitis. Journal of the American Academy of Dermatology. 2015;72(1):140-5.
DOI: 10.1016/j.jaad.2014.08.043
[8] Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, et al. Penicillin to prevent recurrent leg cellulitis. N Engl J Med. 2013;368(18):1695-703.
DOI: 10.1056/NEJMoa1206300 PMID: 23635049
[9] McNamara DR, Tleyjeh IM, Berbari EF, Lahr BD, Martinez J, Mirzoyev SA, et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007;167(7):709-15. DOI: 10.1001/archinte.167.7.709 PMID: 17420430
[10] Karppelin M, Syrjänen J, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case–control study. Clinical Microbiology and Infection. 2010;16(6):729-34.
DOI: 10.1111/j.1469-0691.2009.02906.x
[11] Halpern J, Holder R, Langford NJ. Ethnicity and other risk factors for acute lower limb cellulitis: a UK‐based prospective case–control study. British Journal of Dermatology. 2008;158(6):1288-92. DOI: 10.1111/j.1365-2133.2008.08489.x
[12] Scheinfeld NS. Obesity and dermatology. Clin Dermatol. 2004;22:303–9. DOI: 10.1016/j.clindermatol.2004.01.001
[13] Li A, Wang N, Ge L, Xin H, Li W. Risk factors of recurrent erysipelas in adult Chinese patients: a prospective cohort study. BMC Infect Dis. 2021;21:1–7.
DOI: 10.1186/s12879-020-05710-3
[14] Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clin Microbiol Infect. 2010;16(6):729-34. DOI: 10.1111/j.1469-0691.2009.02906.x PMID: 19694769
[15] Mokni M, Dupuy A, Denguezli M, Dhaoui R, Bouassida S, Amri M, et al. Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study. Dermatology. 2006;212(2):108-12. DOI: 10.1159/000090649
[16] Norazirah MN, Khor IS, Adawiyah J, Tamil AM, Azmawati MN. The risk factors of lower limb cellulitis: A case-control study in a tertiary centre. Malays Fam Physician. 2020;15(1):23-29.
PMID: 32284801
[17] Tianyi FL, Mbanga CM, Danwang C, Agbor VN. Risk factors and complications of lower limb cellulitis in Africa: a systematic review. BMJ Open. 2018;8(7):e021175.
DOI: 10.1136/bmjopen-2017-021175
[18] Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes care. 2003;26(2):510-3.
DOI: 10.2337/diacare.26.2.510
[19] Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infectious disease clinics of North America. 2007;21(3):617-38. DOI: 10.1016/j.idc.2007.07.003
[20] Oumeish OY. Skin disorders in patients with diabetes. Clinics in dermatology. 2008;26(3):235-42.
DOI: 10.1016/j.clindermatol.2007.10.015
[21] Cannon J, Dyer J, Carapetis J, Manning L. Epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study. Clin Microbiol Infect. 2018;24:1084–8.
DOI: 10.1016/j.cmi.2018.01.023
[22] Norimatsu Y, Ohno Y. Predictors for readmission due to cellulitis among Japanese patients. J Dermatol. 2021;48:681–4.
DOI: 10.1111/1346-8138.15771
 
							 
						 
            
         
             
            